A randomized phase 2 trial to evaluate the clinical efficacy of two high tigecycline dosage regimens versus imipenem/cilastatin in hospital-acquired pneumonia - Ramirez, J; Dartois, N; Gandjini, H (Antimicrob Agents Chemother, 2013)
et al.